TOTAL EM
  • Emergency Professionals
  • For The Public
  • Our Friends
  • About Us and Disclaimer
  • Twitter
  • LinkedIn
  • Facebook
  • Contact Us

Emergency Professionals

Podcast #55 - So Much Blood! Tranexamic Acid (TXA) in Emergency Medicine

8/8/2017

1 Comment

 
Picture
Tranexamic acid (TXA) is an old drug, but one that we in emergency medicine have found love for once again.  In preparation for an upcoming talk at a conference, I realized I had not yet made a post regarding TXA.  This is a quick summary of TXA and links to a lot of great #FOAMed resources out there you can also check out regarding the same.  I have also included one bit that I have recently found very successful but with little evidence currently.  Listen to the podcast for more!
Probably the most well-known example of using TXA in emergency medicine is from the CRASH-2 Trial which was an international study using TXA in trauma.  The NNT for this treatment is 1 in 67 which is not bad for a low cost intervention without a real NNH.  Multiple groups like Core EM, EmCrit, JEMS, emDOCS, The Bottom Line, and the SGEM have all made articles on this discussion.  EmCrit even did a second post for the doubters out there on this study.  Whether or not you believe the findings, you should listen to that post.  The easiest way to consider when to give TXA is if the patient is needing blood.  If they need blood, they probably need TXA.  Time is of the essence since less than three hours needs to be the goal.  Later than that means a potential for an increase in mortality.  The easy way to deliver this medication is 1000mg (1 gram) over 10 minutes and then another gram delivered over the next 8 hours to match the study.  This is important to know, especially if you work in a rural or remote setting where you have to make these decisions quickly before you transport this patient to definitive care.

The WOMAN Trial has also hit the press recently.  There is a lot more controversy regarding this trial and it is something you will need to research more to make your own decision (like any other really).  Some of my favorite posts are by REBEL EM, FOAMcast, Broome Docs, The Bottom Line, and EM Lit of Note.  If you were to read them all there is evidence that some are strongly for the results and believe TXA should be used while others have their reservations.  This will most likely remain controversial but in the end, with massive bleeding, there is a role for TXA.

Topical bleeding control is another area of benefit for TXA.  Epistaxis is a great area for TXA to shine more with newer evidence.  One RCT from 2013 outlined a specific approach and this was very well covered by the SGEM and emDOCS.  Though this trial used it basically in packing, an atomizer could be used but this really has not been study in such a form.

Oral bleeds are another type of bleeding that we sometimes see in emergency medicine.  The best post out there is by REBEL EM for this topic.  In that same post he also talks about safety of TXA and using this drug in hyphemas.  This has also been talked about on ER CAST though and is worth the listen.

My final area of using TXA is with cutaneous bleeds.  The are usually the little varicose vein bleeds or the lacerations that are bleeding just enough to be difficult that cannot or should not be controlled by other measures.  When direct pressure is not enough or other methods such as Surgicel or silver nitrite stick are contraindicated (or even failed), what comes next?  In the small bleed that will just not stop there is nothing to suture and nothing to really compress.  Tourniquets may stop bleeding temporarily but do not actually correct the problem.  Topical TXA (anecdotally) has been very beneficial in such cases.  ER CAST briefly had this mentioned in an episode recently.  Academic Life in Emergency Medicine also came up with a paste that could help which could be applied to such bleeds.  Other methods of delivery could be by an atomizer or placing on a bandage (or even something like Surgicel).  Ultimately, TXA can be your friend and it would be even better with more evidence.

Let us know what you think by giving us feedback here in the comments section or contacting us on Twitter or Facebook.  Remember to look us up on Libsyn and on iTunes.  If you have any questions you can also comment below, email at thetotalem@gmail.com, or send a message from the page.  Please check our bandwidth sponsor, FunnyRx, too.  We hope to talk to everyone again soon.  ​Until then, continue to provide total care everywhere.
podcast_55.mp3
File Size: 17058 kb
File Type: mp3
Download File

1 Comment
Advatx Laser link
8/17/2022 11:59:48 am

Thank you for sharing this information.

Reply



Leave a Reply.

    Libsyn and iTunes

    We are now on Libsyn and iTunes ​for your listening pleasure!

    Archives

    July 2022
    June 2022
    June 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    April 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016

    Categories

    All

    Picture

    RSS Feed

Our Pages

Emergency Professionals
For the Public
Our Friends

Support

About Us and Disclaimer
Contact Us
© COPYRIGHT 2015. ALL RIGHTS RESERVED.
  • Emergency Professionals
  • For The Public
  • Our Friends
  • About Us and Disclaimer
  • Twitter
  • LinkedIn
  • Facebook
  • Contact Us